Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study

NCT07145281 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gender Dysphoria, Adult
Blood Coagulation
Coagulation Factors
Transgender Persons, M01.777.500
Hemostasis
Transgender Women

Interventions

DRUG: Estradiol (E2)
DRUG: Cyproterone Acetate (Androcur, BAY94-8367)

Sponsor

Tel-Aviv Sourasky Medical Center